CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell ALL

CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell ALL

Invited Research Meeting - Prof. Kara Davis - Predicting Patient Outcomes in Childhood LeukemiaПодробнее

Invited Research Meeting - Prof. Kara Davis - Predicting Patient Outcomes in Childhood Leukemia

CAR-T therapy in pediatric and adult ALLПодробнее

CAR-T therapy in pediatric and adult ALL

Efficacy of bispecific CD19/CD22 CAR T-cells in B-cell malignanciesПодробнее

Efficacy of bispecific CD19/CD22 CAR T-cells in B-cell malignancies

CAR T-cells in adult ALLПодробнее

CAR T-cells in adult ALL

CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s ExperienceПодробнее

CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s Experience

Актуальное